These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 33811565)
1. Pseudouridylate Synthase 7 Promotes Cell Proliferation and Invasion in Colon Cancer Through Activating PI3K/AKT/mTOR Signaling Pathway. Du J; Gong A; Zhao X; Wang G Dig Dis Sci; 2022 Apr; 67(4):1260-1270. PubMed ID: 33811565 [TBL] [Abstract][Full Text] [Related]
2. A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway. Zhang X; Liu Z; Chen S; Li H; Dong L; Fu X J Ethnopharmacol; 2022 Jan; 283():114742. PubMed ID: 34655668 [TBL] [Abstract][Full Text] [Related]
3. TBC1D10B promotes tumor progression in colon cancer via PAK4‑mediated promotion of the PI3K/AKT/mTOR pathway. Chi XJ; Song YB; Zhang H; Wei LQ; Gao Y; Miao XJ; Yang ST; Lin CY; Lan D; Zhang X Apoptosis; 2024 Aug; 29(7-8):1185-1197. PubMed ID: 38824479 [TBL] [Abstract][Full Text] [Related]
4. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway. Zhang X; Shi H; Tang H; Fang Z; Wang J; Cui S Int J Mol Med; 2015 May; 35(5):1301-8. PubMed ID: 25760926 [TBL] [Abstract][Full Text] [Related]
5. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway. Yin F; Huang X; Xuan Y Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway. Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851 [TBL] [Abstract][Full Text] [Related]
7. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation. Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973 [TBL] [Abstract][Full Text] [Related]
8. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mTOR signaling pathway]. Tao SN; Liu XC; Wang YY; Yang H Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356 [No Abstract] [Full Text] [Related]
9. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling. Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424 [TBL] [Abstract][Full Text] [Related]
10. Cleavage stimulation factor 2 promotes malignant progression of liver hepatocellular carcinoma by activating phosphatidylinositol 3'-kinase/protein kinase B/mammalian target of rapamycin pathway. Zhang MH; Liu J Bioengineered; 2022 Apr; 13(4):10047-10060. PubMed ID: 35412944 [TBL] [Abstract][Full Text] [Related]
11. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway. Wu XL; Wang LK; Yang DD; Qu M; Yang YJ; Guo F; Han L; Xue J J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839 [TBL] [Abstract][Full Text] [Related]
12. LINC00941 promoted in vitro progression and glycolysis of laryngocarcinoma by upregulating PKM via activating the PI3K/AKT/mTOR signaling pathway. Li Z; Jin Q; Sun Y J Clin Lab Anal; 2022 Jul; 36(7):e24406. PubMed ID: 35588431 [TBL] [Abstract][Full Text] [Related]
13. Saikosaponin B4 Suppression Cancer Progression by Inhibiting SW480 and SW620 Cells Proliferation via the PI3K/AKT/mTOR Pathway in Colon Cancer. Zhang Y; Lin L; Wang Y; Liu Z; Xia W; Sui H; Fu X Curr Cancer Drug Targets; 2022; 22(11):889-903. PubMed ID: 35762543 [TBL] [Abstract][Full Text] [Related]
14. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway. Zheng J; Liu C; Shi J; Wen K; Wang X Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077 [TBL] [Abstract][Full Text] [Related]
15. [Inhibition effect of active fraction from clove on PI3K/Akt/mTOR signaling pathway to induce apoptosis of human colon cancer HCT116 cells]. Zhao G; Zhang D; Yang XH; Li XF; Liu MH Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(5):1197-1204. PubMed ID: 33787115 [TBL] [Abstract][Full Text] [Related]
16. Elucidating the Mechanism of Agrimonolide in Treating Colon Cancer Based on Network Pharmacology. Yu L; Gai Y Drug Des Devel Ther; 2023; 17():2209-2222. PubMed ID: 37533972 [TBL] [Abstract][Full Text] [Related]
17. P300 increases CSNK2A1 expression which accelerates colorectal cancer progression through activation of the PI3K-AKT-mTOR axis. Liu J Exp Cell Res; 2023 Sep; 430(1):113694. PubMed ID: 37391010 [TBL] [Abstract][Full Text] [Related]
18. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway. Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788 [TBL] [Abstract][Full Text] [Related]
19. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR. Zhang S; Wang M; Li Q; Zhu P Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412 [TBL] [Abstract][Full Text] [Related]
20. Fibroblast-derived CXCL12/SDF-1α promotes CXCL6 secretion and co-operatively enhances metastatic potential through the PI3K/Akt/mTOR pathway in colon cancer. Ma JC; Sun XW; Su H; Chen Q; Guo TK; Li Y; Chen XC; Guo J; Gong ZQ; Zhao XD; Qi JB World J Gastroenterol; 2017 Jul; 23(28):5167-5178. PubMed ID: 28811711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]